%0 Journal Article %T Core-shell Pluronic F127/chitosan based nanoparticles for effective delivery of methotrexate in the management of rheumatoid arthritis. %A Shafiq A %A Madni A %A Khan S %A Sultana H %A Sumaira %A Shah H %A Khan S %A Rehman S %A Nawaz M %A Shafiq A %A Madni A %A Khan S %A Sultana H %A Sumaira %A Shah H %A Khan S %A Rehman S %A Nawaz M %A Shafiq A %A Madni A %A Khan S %A Sultana H %A Sumaira %A Shah H %A Khan S %A Rehman S %A Nawaz M %J Int J Biol Macromol %V 213 %N 0 %D Jul 2022 31 %M 35661673 %F 8.025 %R 10.1016/j.ijbiomac.2022.05.192 %X This study was designed to improve oral bioavailability of the methotrexate (MTX) by sustaining its release profile and integration into core-shell polymeric nanoparticles. The self-micellization and ionotropic gelation technique was employed which resulted into spherical shaped nanoparticles (181-417 nm) with encapsulation efficiency of 80.14% to 85.54%. Furthermore, Fourier Transform Infrared Spectroscopy and Differential Scanning Calorimetry analyses were carried out to investigate physicochemical and thermal stability of the produced engineered core shell nanoparticles of the methotrexate. . Entrapment of drug in polymeric core was confirmed by X-ray diffraction analysis. In-vitro sustained release behavior of nanoparticles was observed at pH 6.8 for 48 h while low drug release was observed at pH 1.2 due to pH-responsive nature of Pluronic F127. Acute toxicity study confirmed safety and biocompatible profile of nanoparticles. MTX loaded polymeric nanoparticles ameliorated the pharmacokinetic profile (8 folds greater half-life, 6.26 folds higher AUC0-t and 3.48 folds higher mean residence time). In vivo study conducted in rat model depicted the improved therapeutic efficacy and healing of arthritis through MTX loaded polymeric nanoparticles, preferentially attributable to high accretion of MTX in the inflamed site. In conclusion, MTX loaded polymeric nanoparticles is an attractive drug delivery strategy for an effective management and treatment of rheumatoid arthritis.